GCIA
AVNS

Gabelli & Co Investment Advisers’s Avanos Medical AVNS Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Buy
+84,350
New +$1.97M 0.31% 74

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Gabelli & Co Investment Advisers's AVNS Position: Q2 2026 in Review

Gabelli & Co Investment Advisers opened a new position in Avanos Medical (AVNS) in Q2 2026: 84,350 shares worth $2.1M. The stake represents 0.31% of the portfolio and ranks #74 among its holdings.

286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Gabelli & Co Investment Advisers held 84,350 shares of Avanos Medical worth $2.1M as of Q2 2026.
  • Avanos Medical was a new Gabelli & Co Investment Advisers position in Q2 2026.
  • Avanos Medical made up 0.31% of Gabelli & Co Investment Advisers's portfolio in Q2 2026, its #74 holding.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.